The Imaging Mass Cytometry Laboratory provides cancer researchers with high-dimensional imaging analysis of tumor tissue samples at subcellular resolution. 

In contrast to traditional imaging technologies, such as immunohistochemistry and immunofluorescence, which are capable of staining just two or three protein markers, imaging mass cytometry can simultaneously stain up to 40 protein markers. It is one of the leading technologies in spatial biology and provides comprehensive and multiparametric analyses of tissue samples at the single-cell level with spatial distribution. Imaging mass cytometry can be used for 3D imaging and can be combined with RNAscope™ technology to simultaneously detect antibody markers and mRNA transcripts.

Portrait photo

Contact Christine Newkirk, project manager, at IMCFNLCR@nih.gov for service requests or questions.

Collaboration Opportunities

All investigators with a cancer-focused project are welcome to request a service from the laboratory. 

Slide loader-hyperion machine
Submissions accepted on a rolling basis

Request our services

We work with intramural staff and extramural nonprofit research organizations interested in studying tumor heterogeneity and interrogating tumor microenvironments, interactions between tumors and stromal cells, and the roles of immune cell subpopulations in tumor progression or suppression in animal models and cancer patient samples. We provide access to technology for pilot studies, collection of preliminary data, and investigations to complement ongoing research. 

Technology to assess tissue microenvironments 

The laboratory is equipped with a Standard BioTools™ Hyperion XTi™ Imaging System, a multiplexed tissue imager that uses metal-tagged antibodies, instead of fluorophores, to simultaneously and reliably acquire 40-plus protein and RNA markers, without autofluorescence interference. 
Using the Hyperion XTi™ Imaging System, the IMC Laboratory performs spatial proteomics analyses of formalin-fixed, paraffin-embedded tissue samples; tissue microarrays; fresh-frozen tissues; and smeared cells on glass slides. We can stain specimens with metal-labeled antibodies and obtain high-dimensional images of up to 40 protein markers simultaneously, allowing researchers to interrogate the protein markers’ expression at subcellular resolution.

Imaging mass cytometry laboratory workflow  

Working with researchers, we develop metal-labeled antibody panels then validate them with positive and negative control tissue slides/tissue microarrays. Once an antibody panel is finalized, we use 4–5µm sections of fresh-frozen or formalin-fixed, paraffin-embedded tissue, or smeared cells, then stain them with up to 40 different metal-labeled antibodies. The Regions of Interest (ROI) are ablated with the Hyperion XTi™ laser ablation unit then the content is ionized and transferred to a time-of-flight mass spectrometer, which resolves it based on its atomic mass.

Video file
An end-to-end workflow for multiplexed image processing and analysis. Nat Protoc 18, 3565–3613 (2023). Windhager, J., Zanotelli, V.R.T., Schulz, D. et al.

After overlaying the single isotope signals for each ROI, we generate high-dimensional images that provide spatial and subcellular resolution of the tissue samples and the raw data from the instrument is shared with the investigator’s laboratory. If requested, we provide data analysis using project-dependent cell segmentation coupled with the Bodenmiller Lab pipeline for downstream analysis.

 

Image
Mass cytometry image of infiltration of CD8a T cells and Macrophages
Infiltration of CD8a T cells and Macrophages (CD68) in high NOS2 expressing ER-negative Breast Cancer. Clinical sample from Dr. David Wink laboratory.

Image
Mass cytometry image of expression in non small cell lung cancer
Expression of DNA-IR, β-catenin, Vimentin,CD3, and CD20 in Non small Cell Lung Cancer (NSCLC).
Image
Mass cytometry image of PDX mouse models
Identification of CTCs from the PDX mouse models, showing expression of human specific PanCK, EpCAM, E-cadherin, COX2 and β- catenin in CTCs with pool of CD45+ve mouse leukocytes in the background. Pre-Clinical sample from Dr. Esta Sterneck laboratory.

Our capabilities and specializations

Additional Content

Individualized support for investigators

We work with researchers to design customized and validate metal-labeled antibody panels and optimize the staining protocols. 
We maintain a state-of-the-art pipeline for quantitative analysis of high-dimensional, single-cell data. The laboratory has developed and validated several metal-labeled antibody panels to achieve spatial and subcellular resolution of tissue samples.
 

Additional Content
  • Epithelial-to-mesenchymal transition markers (EMTs) 

  • Metabolic protein markers  

  • Tumor microenvironments   

  • Protein markers targeted to specific cancer types  

  • Proliferation markers   

  • Cancer stem cell markers